EA200900816A1 - Антибактериальные соединения и способы их получения - Google Patents

Антибактериальные соединения и способы их получения

Info

Publication number
EA200900816A1
EA200900816A1 EA200900816A EA200900816A EA200900816A1 EA 200900816 A1 EA200900816 A1 EA 200900816A1 EA 200900816 A EA200900816 A EA 200900816A EA 200900816 A EA200900816 A EA 200900816A EA 200900816 A1 EA200900816 A1 EA 200900816A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
antibacterial
connections
production
compounds
Prior art date
Application number
EA200900816A
Other languages
English (en)
Inventor
Маттью Дж. Ламарч
Дженнифер А. Лидз
Филипп Крастель
Ханс-Ульрих Нэгели
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of EA200900816A1 publication Critical patent/EA200900816A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Настоящее изобретение относится к новым антибиотическим соединениям, их фармацевтически приемлемым солям и производным и к способам получения таких соединений.
EA200900816A 2006-12-20 2007-12-19 Антибактериальные соединения и способы их получения EA200900816A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87105106P 2006-12-20 2006-12-20
US88959107P 2007-02-13 2007-02-13
US89298807P 2007-03-05 2007-03-05
PCT/US2007/025955 WO2008082562A2 (en) 2006-12-20 2007-12-19 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production

Publications (1)

Publication Number Publication Date
EA200900816A1 true EA200900816A1 (ru) 2009-12-30

Family

ID=39166701

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900816A EA200900816A1 (ru) 2006-12-20 2007-12-19 Антибактериальные соединения и способы их получения

Country Status (15)

Country Link
US (1) US8183341B2 (ru)
EP (1) EP2097423B1 (ru)
JP (1) JP5230647B2 (ru)
KR (1) KR20090082504A (ru)
CN (1) CN101563353B (ru)
AT (1) ATE500259T1 (ru)
AU (1) AU2007339279A1 (ru)
BR (1) BRPI0720542A2 (ru)
CA (1) CA2673506A1 (ru)
DE (1) DE602007012935D1 (ru)
EA (1) EA200900816A1 (ru)
MX (1) MX2009006745A (ru)
PL (1) PL2097423T3 (ru)
PT (1) PT2097423E (ru)
WO (1) WO2008082562A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0812340A2 (pt) * 2007-06-04 2015-01-27 Novartis Ag Macrociclos e seus usos
CN101945866B (zh) 2007-12-12 2013-06-19 诺瓦提斯公司 氨基噻唑化合物及其用途
JP2011116662A (ja) * 2008-03-26 2011-06-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規抗生物質ｓｆ２８７６物質、その製造法および医薬組成物
KR101663234B1 (ko) 2011-04-18 2016-10-07 명지대학교 산학협력단 노노무라에아 종으로부터의 고리형 펩티드, 그에 대한 생산 프로세스 및 이를 포함하는 마이코박테리아 관련 질병의 치료 혹은 예방을 위한 약학적 조성물
JP6273279B2 (ja) * 2012-08-14 2018-01-31 コーリア リサーチ インスティテュート オブ ケミカル テクノロジー ストレプトマイセス・スコプリリディスｋｒ−００１株またはその培養液を活性成分として含む雑草防除用組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740299A (en) * 1985-05-14 1988-04-26 Parker Hannifin Corporation Filter assembly with threaded collection bowl
US5202241A (en) 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ES2066914T3 (es) 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.
DK0451486T3 (da) 1990-03-08 1995-05-08 Lepetit Spa Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DE69224497T2 (de) 1991-08-30 1998-07-02 Biosearch Italia Spa Faktor C2a des Antibiotikums CE 2270
US5882900A (en) 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
CA2151616A1 (en) 1992-12-22 1994-07-07 Sergio Stella Antibiotics ge 37468 a, b and c
US5547686A (en) 1994-08-15 1996-08-20 Clemson University Feed supplements for ruminants and method for using same
JPH10508476A (ja) 1994-11-08 1998-08-25 グルポ・レペチツト・エス・ピー・エイ 抗生物質ｇｅ２２７０因子ｄ▲下２▼を得るための微生物変換法
DK0801655T3 (da) 1995-02-07 1999-02-08 Biosearch Italia Spa Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika
DK0808326T3 (da) 1995-02-07 2001-10-01 Biosearch Italia Spa Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika
JP2000505438A (ja) 1996-02-14 2000-05-09 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ＧＥ２２７０因子Ｃ▲下２ａ▼、Ｄ▲下２▼およびＥの誘導体
DE10160497A1 (de) * 2001-12-08 2003-06-12 Mann & Hummel Filter Verfahren und Vorrichtung zum Speichern von aus Kraftstoff ausgefiltertem Wasser
ES2364269T3 (es) 2002-06-17 2011-08-30 Naicons S.C.A.R.L. Uso de derivado de amida de ge 2270 factor a3 para el tratamiento del acné.
JP2008513486A (ja) 2004-09-22 2008-05-01 メルク エンド カムパニー インコーポレーテッド 抗生物質化合物
PE20080103A1 (es) 2006-05-31 2008-04-03 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu

Also Published As

Publication number Publication date
US8183341B2 (en) 2012-05-22
WO2008082562A2 (en) 2008-07-10
WO2008082562A3 (en) 2008-11-13
BRPI0720542A2 (pt) 2014-01-21
CN101563353B (zh) 2012-06-27
CN101563353A (zh) 2009-10-21
DE602007012935D1 (de) 2011-04-14
KR20090082504A (ko) 2009-07-30
MX2009006745A (es) 2009-08-19
AU2007339279A1 (en) 2008-07-10
EP2097423B1 (en) 2011-03-02
PT2097423E (pt) 2011-06-01
ATE500259T1 (de) 2011-03-15
PL2097423T3 (pl) 2011-07-29
US20100093615A1 (en) 2010-04-15
CA2673506A1 (en) 2008-07-10
JP5230647B2 (ja) 2013-07-10
EP2097423A2 (en) 2009-09-09
JP2010513512A (ja) 2010-04-30

Similar Documents

Publication Publication Date Title
NL301256I2 (nl) cedazuridine, of een farmaceutisch aanvaardbaar zout daarvan
NL301202I1 (nl) Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline
CY1119121T1 (el) Αμορφο αλας ενος μακροκυκλικου αναστολεα του hcv
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA200801381A1 (ru) Производные пиримидина
CY1118093T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt
EA201070786A1 (ru) Бензофуропиримидиноны
ITBO20060719A1 (it) Macchina per la produzione di filtri composti.
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
EA201001848A1 (ru) Производные пиразина в качестве блокаторов эпителиальных натриевых каналов
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
ECSP11010980A (es) Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas
WO2007141283A3 (en) Salts and crystalline salt forms of an 2-indolinone derivative
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
BRPI0821102A2 (pt) Preparação de derivados de di-hidropirrol como intermediários
EA200900397A1 (ru) Новые соединения диосметина, способ их получения и фармацевтические композиции, которые их содержат
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA201070467A1 (ru) Способ модификации твердого состояния соединения и соаморфные композиции, полученные этим способом
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
NO20074047L (no) Ny fremgangsmate for fremstilling av substituerte indoler
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
EA200900816A1 (ru) Антибактериальные соединения и способы их получения
DOP2011000154A (es) 3-aminociclopentancarboxamidas
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
NO20065157L (no) Biotransformasjon av colchicinoidforbindelser